Rigel Pharmaceuticals Inc (RIGL)

Retained Earnings

-$997.10M

Quarterly · Period ending: · USD

RIGL logo

RIGL Retained Earnings

Latest reported-$997.10M
RIGL Quarterly Retained Earnings (-$53.98M → -$997.10M)
High-resolution chart · PNG

RIGL retained earnings history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Rigel Pharmaceuticals Inc Retained Earnings — Quarterly (USD)
Period endingRetained Earnings (USD)
-997,097,000
-1,014,387,000
-1,023,041,000
-1,291,106,000
-1,319,006,000
-1,378,619,000
-1,390,065,000
-1,404,406,000
-1,416,827,000
-1,415,797,000
-1,407,550,000
-1,408,287,000
-1,402,595,000
-1,395,995,000
-1,382,459,000
-1,383,860,000
-1,364,823,000
-1,351,331,000
-1,323,886,000
-1,301,245,000
-1,280,293,000
-1,266,472,000
-1,305,972,000
-1,286,735,000
-1,272,561,000
-1,254,985,000
-1,276,228,000
-1,259,028,000
-1,247,538,000
-1,226,932,000
-1,209,334,000
-1,212,562,000
-1,188,796,000
-1,163,239,000
-1,138,854,000
-1,112,983,000
-1,095,323,000
-1,076,176,000
-1,060,862,000
-1,045,272,000
-1,022,643,000
-1,009,110,000
-991,646,000
-978,959,000
-972,287,000
-958,375,000
-940,182,000
-917,910,000
-896,968,000
-871,577,000
-849,274,000
-832,413,000
-808,589,000
-785,821,000
-760,247,000
-734,775,000
-709,319,000
-684,581,000
-661,407,000
-635,620,000
-617,689,000
-596,215,000
-575,434,000
-558,195,000
-608,628,000
-635,657,000
-613,324,000
-588,231,000
-561,580,000
-531,699,000
-501,777,000
-468,413,000
-430,722,000
-396,693,000
-369,431,000
-350,429,000
-331,485,000
-312,240,000
-295,159,000
-279,703,000
-268,321,000
-265,991,000
-257,522,000
-248,629,000
-235,723,000
-223,430,000
-212,266,000
-197,540,000
-181,404,000
-169,062,000
-156,011,000
-144,150,000
-133,080,000
-122,614,000
-114,814,000
-106,744,000
-96,602,000
-86,156,000
-77,784,000
-71,673,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.